Evaluation of Effectiveness of Dapagliflozin Risk Minimisation Measures in Type 1 Diabetes

Project Details

StatusFinished
Effective start/end date22/07/20 → 1/09/20

Funding

  • Non-EU industry, commerce and public corporations: £11,586.00